Skip to Main content Skip to Navigation
Master Thesis

Place de la rétigabine (TROBALT) dans la stratégie thérapeutique de l'épilepsie chez l'adulte

Abstract : The thesis deals with the place of retigabine in the therapeutic strategy of epilepsy in adults. The unique mechanism of action of this molecule, as well as any side effects, are presented. This molecule has undergone a correction of the authorization on the market in 2013 because of pigment changes in various tissues. This also leads to a change of the indication of the antiepileptic and various recommendations for prescribers. Retigabin is an antiepileptic drug used in the final intention, in combination with the antiepileptic medicine in adults, in drug-resistant partial epilepsy.
Document type :
Master Thesis
Complete list of metadatas

Cited literature [59 references]  Display  Hide  Download

https://dumas.ccsd.cnrs.fr/dumas-01758174
Contributor : Santé Rennes 1 <>
Submitted on : Tuesday, June 5, 2018 - 11:28:51 AM
Last modification on : Thursday, July 9, 2020 - 12:30:44 PM

File

ROUSTAISarah.pdf
Files produced by the author(s)

Identifiers

  • HAL Id : dumas-01758174, version 1

Collections

Citation

Sarah Roustai. Place de la rétigabine (TROBALT) dans la stratégie thérapeutique de l'épilepsie chez l'adulte. Sciences du Vivant [q-bio]. 2016. ⟨dumas-01758174⟩

Share

Metrics

Record views

18

Files downloads

177